Search Results - Moremi, K.E

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Implementation of a pathology-supported genetic testing framework for return of research results to family members of deceased breast cancer patients with somatic TP53 variants

    Implementation of a pathology-supported genetic testing framework for return of research results to family members of deceased breast cancer patients with somatic TP53 variants by Moremi, K.E., Scott, C.J., de Jager, L.J., Pienaar, R., Zemlin, A.E., Kotze, M.J.

    Published in Breast (Edinburgh)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    MammaPrint risk score distribution in South African breast cancer patients with the pathogenic BRCA2 c.7934delG founder variant: towards application of genomic medicine at the point-of-care

    MammaPrint risk score distribution in South African breast cancer patients with the pathogenic BRCA2 c.7934delG founder variant: towards application of genomic medicine at the poin... by Mampunye, I., Grant, K.A., Peeters, A.V., Torrorey-Sawe, R., French, D.J., Moremi, K.E., Kidd, M., van Eeden, P.C., Pienaar, F.M., van der Merwe, N.C., Kotze, M.J.

    Published in Breast (Edinburgh)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    P117 - Implementation of a pathology-supported genetic testing framework for return of research results to family members of deceased breast cancer patients with somatic TP53 variants

    P117 - Implementation of a pathology-supported genetic testing framework for return of research results to family members of deceased breast cancer patients with somatic TP53 varia... by Moremi, K.E., Scott, C.J., de Jager, L.J., Pienaar, R., Zemlin, A.E., Kotze, M.J.

    Published in Breast (Edinburgh)
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Metachronous Onset of Breast and Bladder Cancer Associated with the BRCA2 c.8162delG Founder Mutation Detected in a Patient with a Low MammaPrint Recurrence Risk

    Metachronous Onset of Breast and Bladder Cancer Associated with the BRCA2 c.8162delG Founder Mutation Detected in a Patient with a Low MammaPrint Recurrence Risk by Mampunye, L, Moremi, K.E, Torrorey-Sawe, R, Grant, K.A, Kotze, M.J

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    P032 - MammaPrint risk score distribution in South African breast cancer patients with the pathogenic BRCA2 c.7934delG founder variant: towards application of genomic medicine at the point-of-care

    P032 - MammaPrint risk score distribution in South African breast cancer patients with the pathogenic BRCA2 c.7934delG founder variant: towards application of genomic medicine at t... by Mampunye, I., Grant, K.A., Peeters, A.V., Torrorey-Sawe, R., French, D.J., Moremi, K.E., Kidd, M., van Eeden, P.C., Pienaar, F.M., van der Merwe, N.C., Kotze, M.J.

    Published in Breast (Edinburgh)
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: